Colorectal Cancer/Polyps Detection

About Origin Sciences

Origin Sciences is pioneering a new approach to gastrointestinal diagnostics centered on the analysis of rectal mucus, a previously underutilized biospecimen. The company's core technology is the OriCol device, a simple, proprietary medical device for collecting high-quality rectal mucosal samples, enabling the detection of biomarkers for conditions like colorectal cancer and adenomatous polyps. By combining this novel sampling method with advanced genomic analysis in its own laboratory, Origin aims to deliver more accurate, cost-effective, and patient-friendly diagnostic pathways. The company is actively engaged in clinical studies and partnerships, such as with Primerdesign, to validate and commercialize its extraction and analysis workflow.

Therapeutic Areas